{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-018385","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2025-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.819380+00:00","generated_at":"2026-05-27T04:39:48.899514+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Karyopharm grants retention equity awards: 412,500 stock options and 206,250 RSUs to three executives","bullets":["Named executives Sohanya Chang, Stuart Poulton, and Reshma Rangwala each receive 137,500 options and 68,750 RSUs, effective Feb 28, 2025.","Options vest 25% on first anniversary, then monthly over 4 years; RSUs vest 50% on each of two consecutive anniversaries.","Full acceleration of awards if termination without cause or for good reason occurs within one year after a change-in-control event.","Exercise price of options equals the closing stock price on the Nasdaq on the grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-018385","json":"https://secwatch.observer/filing/0001193125-25-018385.json","markdown":"https://secwatch.observer/filing/0001193125-25-018385.md","text":"https://secwatch.observer/filing/0001193125-25-018385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/0001193125-25-018385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/d914351d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T04:39:48.899514+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}